Taken together, our findings not only elucidated the molecular mechanism by which FOXO3a/FOXM1 signalling is modulated by SPIN1 but also indicate that targeting SPIN1 might serve as a potential radiosensitizer for NSCLC intervention. The gene discussed is SPIN1; the disease is non-small cell lung carcinoma.